Copenhagen's Aisel Health raises €1.7 million to build AI operating system for psychiatry
Danish healthtech startup Aisel Health has closed a €1.7 million pre-Seed round led by Caesar Ventures to scale its AI platform for psychiatric clinics. The funding will support team growth and a UK market entry ahead of a planned Seed round.

Copenhagen-based Aisel Health has announced the closing of a €1.7 million pre-Seed funding round led by Caesar Ventures. The round also saw participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside existing backers Rockstart and EIFO.
Founded in 2024 by Augusta Klingsten Peytz and Christian Houen, Aisel Health builds software designed to help psychiatric clinics scale operations by delivering relevant patient information to clinicians at the right moment. The company says its platform improves patient experience, eases staff workload, and boosts clinic profitability.
Faster notes, harder-to-find information
According to Aisel Health, while AI note-taking tools have helped reduce clinician burnout by speeding up documentation, this has created a new problem: as notes become quicker to produce, the relevant information within them becomes harder to locate. The company's research, titled "The Documentation Minute", found that psychiatrists spend considerably more time gathering existing patient history from referrals, prior notes, and multiple systems than they do writing the note itself.
Aisel's platform converts consultation recordings, existing documents, and patient accounts into structured, contextual insights available to clinicians before, during, and after appointments. The company states it does not have access to patients' medical records and that patient data is never used to train its AI models. All data is said to be stored and processed on secure servers within Europe, in compliance with GDPR.
The new funding will go toward growing Aisel's clinical and engineering teams and financing its entry into the UK private psychiatry market, as the company prepares for a future Seed funding round.


